HFMA
About the Author
HFMA
Latest Work
HFMA Comments on the HRSA 340B Drug Pricing Program Omnibus Guidance
The 340B program stretches resources for care to indigent and at-risk populations. Without this program, these individuals would find more difficulty in finding ready access to care and medications.
CY16 Medicare Physician Fee Schedule Proposed Rule Fact Sheet
CMS has released a proposed rule revising payment polices under the Medicare Physician Fee Schedule for calendar year 2016 (CY16).
Ask the Experts: Billing Staff Metrics
What are the standards for biller activity and productivity?
FY16 IPPS Final Rule Fact Sheet
This document summarizes the updates to the reimbursement payment rates to hospitals under the inpatient prospective payment system for FY16.
HFMA Comments on CMS’s CY16 Physician Fee Schedule Proposed Rule
HFMA comments on the 2016 Medicare Program; revisions to payment policies (including advance care planning) under the physician fee schedule for CY 2016.
340B Drug Pricing Program Proposed Guidance Summary
This executive summary highlights important components of the Health Resources and Services Administration’s (HRSA) proposed 340B “Mega-Guidance.”
HFMA Comments on CMS’s CCJR Payment Model Proposed Rule
HFMA comments on CMS’s proposed rule for Comprehensive Care for Joint Replacement (CCJR) Payment Model for Acute Care Hospitals Furnishing Lower Extremity Joint Replacement Services.
Comprehensive Care for Joint Replacement Payment Model Proposed Rule Fact Sheet
This fact sheet provides a summary of the new Comprehensive Care for Joint Replacement (CCJR) payment model proposed rule released by CMS.
Ask the Expert: Paying Patient Premiums
Do anti-kickback laws preclude providers from paying premiums for uninsured patients, specifically for the health insurance marketplace plans?
HFMA Comments on the FASB’s Proposal on NFP Financial Statement Presentation
HFMA comments on the FASB’s proposed Accounting Standards Update Not-for-Profit Entities (Topic 958) & Health Care Entities (Topic 954): Presentation of Financial Statements of Not-for-Profit Entities.